Here's What Key Metrics Tell Us About Keurig Dr Pepper (KDP) Q3 Earnings
Werte in diesem Artikel
For the quarter ended September 2025, Keurig Dr Pepper, Inc (KDP) reported revenue of $4.31 billion, up 10.7% over the same period last year. EPS came in at $0.54, compared to $0.51 in the year-ago quarter.The reported revenue represents a surprise of +4.06% over the Zacks Consensus Estimate of $4.14 billion. With the consensus EPS estimate being $0.54, the company has not delivered EPS surprise.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Keurig Dr Pepper performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Net Sales- U.S. Coffee: $991 million versus the four-analyst average estimate of $969.33 million. The reported number represents a year-over-year change of +1.5%.Net Sales- International: $580 million compared to the $552.5 million average estimate based on four analysts. The reported number represents a change of +10.5% year over year.Net Sales- U.S. Refreshment Beverages: $2.74 billion compared to the $2.61 billion average estimate based on four analysts. The reported number represents a change of +14.4% year over year.View all Key Company Metrics for Keurig Dr Pepper here>>>Shares of Keurig Dr Pepper have returned +6.5% over the past month versus the Zacks S&P 500 composite's +2.5% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Beyond Nvidia: AI's Second Wave Is HereThe AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.See "2nd Wave" AI stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Keurig Dr Pepper, Inc (KDP): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Keurig Dr Pepper und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Keurig Dr Pepper
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Keurig Dr Pepper
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: Zacks
Nachrichten zu Keurig Dr Pepper Inc
Analysen zu Keurig Dr Pepper Inc
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.08.2025 | Keurig Dr Pepper Buy | UBS AG | |
| 17.06.2019 | Dr Pepper Snapple Group Outperform | BMO Capital Markets | |
| 11.07.2018 | Dr Pepper Snapple Group Hold | Stifel, Nicolaus & Co., Inc. | |
| 19.06.2018 | Dr Pepper Snapple Group Hold | Stifel, Nicolaus & Co., Inc. | |
| 19.03.2018 | Dr Pepper Snapple Group Outperform | RBC Capital Markets |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.08.2025 | Keurig Dr Pepper Buy | UBS AG | |
| 17.06.2019 | Dr Pepper Snapple Group Outperform | BMO Capital Markets | |
| 11.07.2018 | Dr Pepper Snapple Group Hold | Stifel, Nicolaus & Co., Inc. | |
| 19.06.2018 | Dr Pepper Snapple Group Hold | Stifel, Nicolaus & Co., Inc. | |
| 19.03.2018 | Dr Pepper Snapple Group Outperform | RBC Capital Markets |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 28.07.2017 | Dr Pepper Snapple Group Neutral | UBS AG | |
| 09.01.2017 | Dr Pepper Snapple Group Equal Weight | Barclays Capital | |
| 28.10.2016 | Dr Pepper Snapple Group Neutral | UBS AG | |
| 28.04.2016 | Dr Pepper Snapple Group Neutral | UBS AG | |
| 27.10.2015 | Dr Pepper Snapple Group Sector Perform | RBC Capital Markets |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 01.12.2014 | Dr Pepper Snapple Group Underperform | RBC Capital Markets |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Keurig Dr Pepper Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
